Gyeonggi, South Korea

Young Hoon Choi

This inventor holds 1 USPTO granted patent. Top assignee: Pacific Corporation. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Young Hoon Choi. Retrieved from https://idiyas.com/inventor/young-hoon-choi-bh0a182k

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 18.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Young Hoon Choi: Innovator in Cyclooxygenase-2 Inhibition

Introduction

Young Hoon Choi is a notable inventor based in Kyunggi-do, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific biological pathways.

Latest Patents

Young Hoon Choi holds a patent for a novel class of 4,5-diaryl-3(2H)-furanone derivatives, which serve as cyclooxygenase-2 (COX-2) inhibitors. This invention is particularly important as it provides a means to inhibit COX-2 selectively over COX-1, making it useful for treating inflammation, inflammation-associated disorders, and COX-2 mediated diseases. He has 1 patent to his name.

Career Highlights

Choi is currently associated with Pacific Corporation, where he continues to innovate and develop new therapeutic agents. His work has been instrumental in advancing the understanding of COX-2 inhibitors and their applications in medicine.

Collaborations

He has collaborated with notable colleagues, including Song Seok Shin and Min-Soo Noh, to further enhance the research and development of his inventions.

Conclusion

Young Hoon Choi's contributions to the field of medicinal chemistry, particularly through his patent on COX-2 inhibitors, highlight his role as an influential inventor. His work continues to pave the way for new treatments in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…